Page last updated: 2024-08-26

bosentan anhydrous and Chronic Kidney Failure

bosentan anhydrous has been researched along with Chronic Kidney Failure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konishi, K; Kuriyama, T; Maruoka, M; Nakamura, M; Shigeta, A; Shinohara, M; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Toyama, S; Yasuda, T1
Gosek, K; Grzeszczak, W; Zukowska-Szczechowska, E1
Budde, K; Dingemanse, J; Hocher, B; Liefeldt, L; Neumayer, HH; Rudolph, B; van Giersbergen, PL; Walde, T1
Brochu, E; Grose, JH; Kingma, I; Lacasse, S; Larivière, R; Lebel, M1

Reviews

1 review(s) available for bosentan anhydrous and Chronic Kidney Failure

ArticleYear
[Antihypertensive treatment in patients with diabetes mellitus].
    Polskie Archiwum Medycyny Wewnetrznej, 2002, Volume: 108, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Bosentan; Diabetes Complications; Endothelins; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Losartan; Sulfonamides; Time Factors

2002

Other Studies

3 other study(ies) available for bosentan anhydrous and Chronic Kidney Failure

ArticleYear
[Pulmonary hypertension in a patient on chronic hemodialysis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:1

    Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Sjogren's Syndrome; Sulfonamides

2009
Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:5

    Topics: Adult; Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Kidney Failure, Chronic; Scleroderma, Systemic; Sulfonamides

2004
Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
    Journal of the American Society of Nephrology : JASN, 1999, Volume: 10, Issue:7

    Topics: Animals; Blood Pressure; Bosentan; Creatinine; Endothelin Receptor Antagonists; Endothelin-1; Erythropoietin; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Recombinant Proteins; Sulfonamides

1999
chemdatabank.com